When to sell HIMS
The honest answer to "when should I sell Hims & Hers Health, Inc." is not a price target. It is the moment the reasons you bought it stop being true. Here is a thesis-based checklist for HIMS holders.
The HIMS sell checklist
- 1Did a reason break, or just the price? A drawdown with your thesis intact is not a sell signal. A contradicted pillar is.
- 2Check the latest filing and earnings Read what changed against your reasons for owning HIMS, not against the stock chart.
- 3Look for the specific risks HIMS's known risks are below. Watch for any of them turning from possibility into fact.
- 4Re-underwrite, do not anchor If a reason is gone, decide whether you would buy HIMS today on what remains. If not, the position is a hold by inertia.
What you bought HIMS for
Some investors cite Hims & Hers' significant revenue growth of 59.00% year-over-year as a positive indicator of its market potential. Additionally, the company's return on equity (ROE) is 23.73%, suggesting efficient management of equity capital.
The signals that would break it
Conversely, the company has experienced an EPS decline of 3.77% year-over-year, which may raise concerns about profitability. The high P/E ratio of 60.61 could also indicate that the stock is perceived as overvalued relative to earnings.
Where HIMS stands now
Hims & Hers Health, Inc. has a market capitalization of approximately $7.98B and a current stock price of $30.91, reflecting a day change of +10.16%. The company has a P/E ratio of 60.61 and a revenue growth of 59.00% year-over-year, while EPS growth stands at -3.77%. The stock has traded within a 52-week range of $13.75 to $65.28.
The hard part is noticing
Everyone agrees you should sell when the reasons change. The problem is that the evidence lives in filings and earnings calls, while you spend your attention on the price. Helm closes that gap: you write the reasons you own HIMS, and Helm watches the primary sources against them, then tells you with a dated citation when one breaks. See how thesis monitoring works, or read what could invalidate the HIMS thesis.
Common questions
When should I sell HIMS?
Sell Hims & Hers Health, Inc. when the specific reasons you bought it are contradicted by a filing, an earnings result, or a material news event, not merely when the price falls. A lower price with the thesis intact is a different situation from a broken thesis.
What are the warning signs for HIMS?
The main risks to watch: Conversely, the company has experienced an EPS decline of 3.77% year-over-year, which may raise concerns about profitability. The high P/E ratio of 60.61 could also indicate that the stock is perceived as overvalued relative to earnings.
Is a falling HIMS price a reason to sell?
Not by itself. Price is not a reason. The question is whether the reasons you own HIMS still hold. If they do, a drawdown may be noise; if they do not, the position deserves a fresh decision regardless of price.
Know the moment, not the price.
Helm tells you, with a dated source, when the HIMS thesis breaks. Free to start.
Take the helmThis content is for educational purposes only and does not constitute financial, tax, or investment advice. Helm Terminal is not a registered investment advisor.